Marine Drugs · 2013 · 67 citations · 19 references
Cyanobacterial MetabolismSecondary MetabolitesPharmaceutical ChemistryDrug ResistanceMedicinal ChemistryChlorinated Peptide/polyketide HybridsAntitumor Drug ResearchAnti-cancer AgentBiochemistryDolapyrrolidinone UnitAntimicrobial CompoundDrug DevelopmentPharmacologyBiomolecular EngineeringSmenamide ANatural SciencesPolymer-drug ConjugatePeptide TherapeuticMedicineDrug Discovery
An in-depth study of the secondary metabolites contained in the Caribbean sponge Smenospongia aurea led to the isolation of smenamide A (1) and B (2), hybrid peptide/polyketide compounds containing a dolapyrrolidinone unit. Their structures were elucidated using high-resolution ESI-MS/MS and homo- and heteronuclear 2D NMR experiments. Structures of smenamides suggested that they are products of the cyanobacterial metabolism, and 16S rRNA metagenomic analysis detected Synechococcus spongiarum as the only cyanobacterium present in S. aurea. Smenamides showed potent cytotoxic activity at nanomolar levels on lung cancer Calu-1 cells, which for compound 1 is exerted through a clear pro-apoptotic mechanism. This makes smenamides promising leads for antitumor drug design.
19